Market Tracker

04/17 6:05pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

13.45
Data as of Apr 17
 -0.39 / -2.82%
Today’s Change
8.57
Today|||52-Week Range
20.29
+44.00%
Year-to-Date

Today’s Trading

Previous close13.84
Today’s open13.75
Day’s range13.35 - 13.96
Volume485,552
Average volume (3 months)1,060,019
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-24.93%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book7.59

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...-1.31-4.04%
GWPHGW Pharmaceuticals P...+1.56+3.49%
USNAUSANA Health Science...+0.54+0.71%
TSROTESARO Inc-0.51-2.00%
Data as of 4:01pm ET, 04/17/2014

Financials

Next reporting dateApril 30, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts